Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Paul D Sykes, John P Neoptolemos, Eithne Costello & Christopher M Halloran. (2012) Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. Expert Review of Gastroenterology & Hepatology 6:3, pages 343-356.
Read now
Read now
Susanne Krüger Kjær & Susanne Krüger Kjær. (2007) Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective. Acta Obstetricia et Gynecologica Scandinavica 86:11, pages 1286-1289.
Read now
Read now
Articles from other publishers (20)
Marli Azevedo & Anil K. Patri. 2024. Comprehensive Precision Medicine. Comprehensive Precision Medicine
304
321
.
Xiao Zhang, Dan Meng, Hong Li, Xuefeng Li, Jing Li, Ping Hu, Lu Zhao, Rui Wang, Chaonan Zhao, Chunxia Luo, Weihua Gu, Wenlin Gai, Yang Wang & Liangzhi Xie. (2023) Validation of Luminex immunological and competitive Luminex immunological assays for clinical immunogenicity assessment of a 14‐valent recombinant human papillomavirus vaccine. Journal of Medical Virology 95:8.
Crossref
Crossref
Manju Lekshmy, Chandrasekharan Rajalekshmi Dhanya, Jayashree SatheeshKumar Smrithi, Janaki Anandavallyamma Sindhurani, Jiji Joseph Vandanamthadathil, Jayakrishnan Therthala Veettil, Leelamma Anila, Vishnu Sasidharan Lathakumari, Adhira M. Nayar & Maya Madhavan. (2023) Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape. Pharmaceuticals 16:7, pages 1054.
Crossref
Crossref
Sumel Ashique, Afzal Hussain, Neda Fatima & Mohammad A. Altamimi. (2023) HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective. VirusDisease 34:2, pages 172-190.
Crossref
Crossref
Miao Yu, Xin Chi, Shiwen Huang, Zhiping Wang, Jie Chen, Ciying Qian, Feng Han, Lin Cao, Jinjin Li, Hui Sun, Lizhi Zhou, Tingting Li, Yingbin Wang, Qingbing Zheng, Hai Yu, Jun Zhang, Ningshao Xia, Shaowei Li & Ying Gu. (2022) A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26. Vaccine 40:42, pages 6141-6152.
Crossref
Crossref
Lei Bei, Xiao Zhang, Dan Meng, Shuman Gao, Jilei Jia, Dandan Zhao, Chunxia Luo, Xuefeng Li, Hongbin Qiu & Liangzhi Xie. (2022) Immunogenicity correlation in cynomolgus monkeys between Luminex‐based total IgG immunoassay and pseudovirion‐based neutralization assay for a 14‐valent recombinant human papillomavirus vaccine. Journal of Medical Virology 94:8, pages 3946-3955.
Crossref
Crossref
Amin Azimi, Sheida Heidarian, Homa Zamani, Nastaran Taleghani, Mohsen Dehghani & Ehsan Seyedjafari. (2020) Optimized dose of synthetic analogues of Monophosphoryl lipid A as an effective alternative for formulating recombinant human papillomavirus vaccine. Biologicals 68, pages 60-64.
Crossref
Crossref
Chivani Tailor, Karen A. Eley, Farah Hussain, Christopher Milford, Roddy McMillan, Colin Hopper & Stephen R. Watt-Smith. (2020) What the general dental practitioner needs to know about HPV-related oropharyngeal malignancy. British Dental Journal 229:6, pages 355-360.
Crossref
Crossref
Renjie Wang, Wei Pan, Lei Jin, Weiming Huang, Yuehan Li, Di Wu, Chun Gao, Ding Ma & Shujie Liao. (2020) Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Letters 471, pages 88-102.
Crossref
Crossref
Arvind Gulbake. (2016) Insight to drug delivery aspects for colorectal cancer. World Journal of Gastroenterology 22:2, pages 582.
Crossref
Crossref
Johan M. J. Van den Bergh, Khadija Guerti, Yannick Willemen, Eva Lion, Nathalie Cools, Herman Goossens, Alex Vorsters, Viggo F. I. Van Tendeloo, Sébastien Anguille, Pierre Van Damme & Evelien L. J. M. Smits. (2014)
HPV
vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against
HPV
‐positive tumour cells
. Journal of Cellular and Molecular Medicine 18:7, pages 1372-1380.
Crossref
Crossref
Juhua Zhou. (2014) Advances and Prospects in Cancer Immunotherapy. New Journal of Science 2014, pages 1-13.
Crossref
Crossref
Dae Ho Lee. (2014) Cancer Immunotherapy: The Dawn of the Renaissance after the Medieval Dark Ages. Korean Journal of Medicine 87:3, pages 284.
Crossref
Crossref
Guirong Sun. (2013) Human hsp70 and HPV16 oE7 fusion protein vaccine induces an effective antitumor efficacy. Oncology Reports.
Crossref
Crossref
Linda H. L. Lua & Yap Pang Chuan. 2012. Biopharmaceutical Production Technology. Biopharmaceutical Production Technology
43
77
.
Sally B. Rose, Tolotea Lanumata & Beverley A. Lawton. (2011) Promoting Uptake of the HPV Vaccine: The Knowledge and Views of School Staff. Journal of School Health 81:11, pages 680-687.
Crossref
Crossref
Bree Weaver, Marcia Shew, Brahim Qadadri, Wanzhu Tu, Yan Tong, Cheryl Denski, J. Dennis Fortenberry & Darron Brown. (2011) Natural History of Multiple Human Papillomavirus Infections in Female Adolescents With Prolonged Follow-up. Journal of Adolescent Health 48:5, pages 473-480.
Crossref
Crossref
Richard Brunner, Erika Jensen-Jarolim & Isabella Pali-Schöll. (2010) The ABC of clinical and experimental adjuvants—A brief overview. Immunology Letters 128:1, pages 29-35.
Crossref
Crossref
Thomas Verstraeten, Dominique Descamps, Marie-Pierre David, Toufik Zahaf, Karin Hardt, Patricia Izurieta, Gary Dubin & Thomas Breuer. (2008) Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 26:51, pages 6630-6638.
Crossref
Crossref
Christina L. Airhart, Harold N. Rohde, Carolyn J. Hovde, Gregory A. Bohach, Claudia F. Deobald, Stephen S. Lee & Scott A. Minnich. (2008) Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine. Vaccine 26:44, pages 5554-5561.
Crossref
Crossref